Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia

Undurti N Das1

  • 1UND Life Sciences, 13800 Fairhill Road, Shaker Heights, OH 44120, USA. undurti@hotmail.com

Insights

Schizophrenia may stem from perinatal inflammation, potentially treatable with polyunsaturated fatty acids (PUFAs). Supplementing PUFAs during development and adulthood could prevent and treat this condition.

Area of Science:

  • Neuroscience
  • Immunology
  • Nutritional Psychiatry

Background:

  • Schizophrenia is proposed as a low-grade systemic inflammatory disease originating in the perinatal period.
  • Genetic, environmental, and nutritional factors may interact to increase pro-inflammatory cytokines, damaging fetal neurons and leading to adult-onset schizophrenia.

Purpose of the Study:

  • To explore the role of polyunsaturated fatty acids (PUFAs) in schizophrenia.
  • To investigate PUFAs' neuroprotective and anti-inflammatory mechanisms.
  • To assess the potential of PUFA supplementation in schizophrenia prevention and treatment.

Main Methods:

  • Literature review and theoretical proposal.
  • Analysis of the biochemical pathways involving PUFAs and pro-inflammatory cytokines.
  • Examination of the impact of desaturase enzyme activity on PUFA metabolism.

Main Results:

  • PUFAs and their metabolites exhibit neuroprotective and anti-inflammatory properties, inhibiting pro-inflammatory cytokine production.
  • Reduced PUFA formation due to low desaturase activity may increase inflammation and neuronal damage, predisposing to schizophrenia.
  • PUFAs are crucial for brain development, suggesting a role in schizophrenia etiology.

Conclusions:

  • Perinatal and adult PUFA supplementation may prevent and treat schizophrenia.
  • Synthetic analogs of PUFA metabolites could offer therapeutic benefits for schizophrenia.
  • Addressing PUFA metabolism and inflammation presents a novel therapeutic strategy for schizophrenia.

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Structure of Lipids03:38

Structure of Lipids

Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...